TNF and inflammatory bowel disease: It could be especially true in the severe cases of drug nonresponders, e.g., those one-third of IBD patients who primarily do not respond to infliximab (anti-TNF-α mAb; commonly prescribed drug in IBD) [48] or to other pharmacological therapies.